Treatment of symptomatic uterine fibroids with green tea extract: a pilot randomized controlled clinical study

References

• MerrillRMHysterectomy surveillance in the United States, 1997 through 2005Med Sci Monit200814CR24CR3118160941
   PubMed Web of Science ®Google Scholar
• BairdDDDunsonDBHillMCCousinsDSchecctmanJMHigh cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidenceAm J Obstet Gynecol200318810010712548202
   PubMed Web of Science ®Google Scholar
• ShenSHFennessyFMcDannoldNJoleszFTempanyCImage-guided thermal therapy of uterine fibroidsSemin Ultrasound CT MR2009309110419358440
   PubMed Web of Science ®Google Scholar
• OthmanEEAl-HendyAMolecular genetics and racial disparities of uterine leiomyomasBest Pract Res Clin Obstet Gynaecol20082258960118373954
   PubMed Web of Science ®Google Scholar
• Al-HendyASalamaSGene therapy and uterine leiomyoma: a reviewHum Reprod Update20061238540016603566
   PubMed Web of Science ®Google Scholar
• EzzatiMNorianJMSegarsJHManagement of uterine fibroids in the patient pursuing assisted reproductive technologiesWomens Health (Lond Engl)2009541342119586433
   PubMedGoogle Scholar
• HassanMHOthmanEEHornungDAl-HendyAGene therapy of benign gynecological diseasesAdv Drug Deliv Rev20096182283519446586
   PubMed Web of Science ®Google Scholar
• AttardiBJBurgensonJHildSAReelJRIn vitro antiprogestational/antiglucocorticoid activity and progestin and glucocorticoid receptor binding of the putative metabolites and synthetic derivatives of CDB-2914, CDB-4124, and mifepristoneJ Steroid Biochem Mol Biol20048827728815120421
   PubMed Web of Science ®Google Scholar
• WilliamsARCritchleyHOOseiJThe effects of the selective progesterone receptor modulator asoprisnil on the morphology of uterine tissues after 3 months treatment in patients with symptomatic uterine leiomyomataHum Reprod2007221696170417339234
   PubMed Web of Science ®Google Scholar
• YoshidaSOharaNXuQCell-type specific actions of progesterone receptor modulators in the regulation of uterine leiomyoma growthSemin Reprod Med20102826027320414849
   PubMed Web of Science ®Google Scholar
• ZhangDAl-HendyMRichard-DavisGMontgomery-RiceVRajaratnamVAl-HendyAAntiproliferative and proapoptotic effects of epigallocatechin gallate on human leiomyoma cellsFertil Steril2010941887189319819432
   PubMed Web of Science ®Google Scholar
• US Department of AgricultureUSDA database for the flavonoid content of selected foods: release 2.12007 Available from: http://www.ars.usda.gov/SP2UserFiles/Place/12354500/Data/Flav/Flav02-1.pdfAccessed May 10, 2013
   Google Scholar
• KhanNAfagFSaleemMAhmadNMukhtarHTargeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-galleteCancer Res2006662500250516510563
   PubMed Web of Science ®Google Scholar
• WolframSEffects of green tea and EGCG on cardiovascular and metabolic healthJ Am Coll Nutr200726373S388S17906191
   PubMed Web of Science ®Google Scholar
• AhnWSYooJHuhSWProtective effects of green tea extracts (polyphenon E and EGCG) on human cervical lesionsEur J Cancer Prev20031238339014512803
   PubMed Web of Science ®Google Scholar
• ChowHHHakimIAViningDREffects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of polyphenon E in healthy individualsClin Cancer Res2005114627463315958649
   PubMed Web of Science ®Google Scholar
• LuoHTangLTangMPhase IIa chemoprevention trial of green tea polyphenols in high-risk individuals of liver cancer: modulation of urinary excretion of green tea polyphenols and 8- hydroxydeoxyguanosineCarcinogenesis20062726226815930028
   PubMed Web of Science ®Google Scholar
• ZhangDAl-HendyMRichard-DavisGGreen tea extract inhibits proliferation of uterine leiomyoma cells in vitro and in nude miceAm J Obstet Gynecol2010202e1e9
   Web of Science ®Google Scholar
• Al-HendyASalamaSACatechol-O-methyltransferase polymorphism is associated with increased uterine leiomyoma risk in different ethnic groupsJ Soc Gynecol Investig200613136144
   PubMedGoogle Scholar
• LuHMengXYangCSEnzymology of methylation of tea catechins and inhibition of catechol-O-methyltransferase by (-)-epigallocatechin gallateDrug Metab Dispos20033157257912695345
   PubMed Web of Science ®Google Scholar
• ChenDWangCYLambertJDAiNWelshWJYangCSInhibition of human liver catechol-O-methyltransferase by tea catechins and their metabolites: structure-activity relationship and molecular-modeling studiesBiochem Pharmocol20056915231531
   PubMed Web of Science ®Google Scholar
• ShixianQVanCreyBShiJKakudaYJiangYGreen tea extract thermogenesis-induced weight loss by epigallocatechin gallate inhibition of catechol-O-methyltransferaseJ Med Food2006945145817201629
   PubMed Web of Science ®Google Scholar
• SalamaSAHoSLWangHQTenhunenJTilgmannCAl-HendyAHormonal regulation of catechol-O-methyl transferase activity in women with uterine leiomyomasFertil Steril20068625926216730007
   PubMed Web of Science ®Google Scholar
• SpiesJBCoyneKGuaou GuaouNBoyleDSkyrnarz-MurphyKGonzalvesSMThe UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomataObstet Gynecol20029929030011814511
   PubMed Web of Science ®Google Scholar
• WyattKMDimmockPWWalkerTJO’BrienPMDetermination of total menstruation blood lossFertil Steril20017612513111438330
   PubMed Web of Science ®Google Scholar
• NairSAl-HendyAAdipocytes enhance the proliferation of human leiomyoma cells via TNF-α proinflammatory cytokineReprod Sci2011181186119222096007
   PubMed Web of Science ®Google Scholar
• SerafiniMDel RioDYaoDNBettuzziSPelusoIHealth benefits of teaBenzieIFFWachtel-GalorSHerbal Medicine: Biomolecular and Clinical Aspects2nd edBoca Raton (FL)CRC Press2011 Chapter 12
   Google Scholar
• HanSGHanSSToborekMHennigBEGCG protects endothelial cells against PCB 126-induced inflammation through inhibition of AhR and induction of Nrf2-regulated genesToxicol Appl Pharmacol201226118118822521609
   PubMed Web of Science ®Google Scholar
• HosokawaYHosokawaIOzakiKNakanishiTNakaeHMatsuoTTea polyphenols inhibit IL-6 production in tumor necrosis factor superfamily 14-stimulated human gingival fibroblastsMol Nutr Food Res201054S151S15820461739
   PubMed Web of Science ®Google Scholar
• JiangJMoZCYinKEpigallocatechin-3-gallate prevents TNF-alpha-induced NF-kappaB activation thereby upregulating ABCA1 via the Nrf2/Keap1 pathway in macrophage foam cellsInt J Mol Med20122994695622367622
   PubMed Web of Science ®Google Scholar
• LokeWMProudfootJMHodgsonJMSpecific dietary polyphenols attenuate atherosclerosis in apolipoprotein E-knockout mice by alleviating inflammation and endothelial dysfunctionArterioscler Thromb Vasc Biol20103074975720093625
   PubMed Web of Science ®Google Scholar
• OzdemirSCelikCGezgincKKiresiDEsenHEvaluation of endometrial thickness with transvaginal ultrasonography and histopathology in premenopausal women with abnormal vaginal bleedingArch Gynecol Obstet201028239539919921229
   PubMed Web of Science ®Google Scholar
• MalekiZKimHSThonseVRJudsonKVinhTNVangRUterine artery embolization with trisacryl gelatin microspheres in women treated for leiomyomas: a clinicopathologic analysis of alterations in gynecologic surgical specimensInt J Gynecol Pathol20102926026820407327
   PubMed Web of Science ®Google Scholar
• ZhangYPengWClarkeJLiuZAcupuncture for uterine fibroidsCochrane Database Syst Rev20101CD00722120091625
   PubMed Web of Science ®Google Scholar
• ViswanathanMHartmannKMcKoyNManagement of uterine fibroids: an update of the evidenceEvid Rep Technol Assess (Full Rep)2007154112218288885
   PubMedGoogle Scholar
• DonnezJHervais VivancosBKudelaMAudebertAJadoulPA randomized, placebo-controlled, dose-ranging trial comparing fulvestrant with goserelin in premenopausal patients with uterine fibroids awaiting hysterectomyFertil Steril2003791380138912798886
   PubMed Web of Science ®Google Scholar
• DeligdischLHirschmannSAltchekAPathologic changes in gonadotropin releasing hormone agonist analogue treated uterine leiomyomataFertil Steril1997678378419130887
   PubMed Web of Science ®Google Scholar
• FriedmanAJHoffmanDIComiteFBrownellerRWMillerJDTreatment of leiomyomata uteri with leuprolide acetate depot: a doubleblind, placebo-controlled, multicenter study. The Leuprolide Study GroupObstet Gynecol1991777207251901638
   PubMed Web of Science ®Google Scholar
• KhanKNKitajimaMHirakiKChanges in tissue inflammation, angiogenesis and apoptosis in endometriosis, adenomyosis and uterine myoma after GnRH agonist therapyHum Reprod20102564265320008888
   PubMed Web of Science ®Google Scholar
• PalombaSRussoTOrioFJrEffectiveness of combined GnRH analogue plus raloxifene administration in the treatment of uterine leiomyomas: a prospective, randomized, single-blind, placebo-controlled clinical trialHum Reprod2002173213321912456626
   PubMed Web of Science ®Google Scholar
• SteinauerJPrittsEAJacksonRJacobyAFSystematic review of mifepristone for the treatment of uterine leiomyomataObstet Gynecol20041031331133615172874
   PubMed Web of Science ®Google Scholar
• DonnezJTomaszewskiJVasquezFUlipristal acetate versus leuprolide acetate for uterine fibroidsN Engl J Med201236642143222296076
   PubMed Web of Science ®Google Scholar
• DonnezJTatarchukTFBouchardPUlipristal acetate versus placebo for fibroid treatment before surgeryN Engl J Med201236640942022296075
   PubMed Web of Science ®Google Scholar
• SurreyESGonadotropin-releasing hormone agonist and add-back therapy: what do the data show?Curr Opin Obstet Gynecol20102228323820498596
   PubMed Web of Science ®Google Scholar
• SpitzIMClinical utility of progesterone receptor modulators and their effect on the endometriumCurr Opin Obstet Gynecol20092131832419602929
   PubMed Web of Science ®Google Scholar
• MavrelosDBen-NagiJHollandTHooWNaftalinJJurkovicDThe natural history of fibroidsUltrasound Obstet Gynecol20103523824220069541
   PubMed Web of Science ®Google Scholar
• BukulmezODoodyKJClinical features of myomasObstet Gynecol Clin North Am200633698416504807
   PubMed Web of Science ®Google Scholar
• Carbonell EsteveJLRiverónAMCanoMMifepristone 2.5 mg versus 5 mg daily in the treatment of leiomyoma before surgeryInt J Womens Health20124758422448109
   PubMedGoogle Scholar
• FiscellaKEisingerSHMeldrumSFengCFisherSGGuzickDSEffect of mifepristone for symptomatic leiomyomata on quality of life and uterine size: a randomized controlled trialObstet Gynecol20061081381138717138770
   PubMed Web of Science ®Google Scholar
• ScottDJStohlerCSEgnatukCMWangHKoeppeRAZubietaJKPlacebo and nocebo effects are defined by opposite opioid and dopaminergic responsesArch Gen Psychiatry20086522023118250260
   PubMed Web of Science ®Google Scholar
• FinnissDGKaptchukTJMillerFBenedettiFBiological, clinical, and ethical advances of placebo effectsLancet201037568669520171404
   PubMed Web of Science ®Google Scholar
• HirzelFHessTZollikoferCQuality control and quality of life after uterine fibroid embolization: long-term resultsGynakol Geburtshilfliche Rundsch2008488493 German18431048
   PubMedGoogle Scholar
• Maheux-LacroixSLemyreMLabergePYLamarreABujoldEUterine artery embolization complicated by uterine perforation at the site of previous myomectomyJ Minim Invasive Gynecol20121912813022196263
   PubMed Web of Science ®Google Scholar
• GuptaJKSinhaALumsdenMAHickeyMUterine artery embolization for symptomatic uterine fibroidsCochrane Database Syst Rev201216CD00507322592701
   PubMed Web of Science ®Google Scholar
• ShenCLChyuMCPenceBCYehJKZhangYFeltonCKGreen tea polyphenols supplementation and tai chi exercise for postmenopausal osteopenic women: safety and quality of life reportBMC Complement Altern Med2010107621143878
   PubMed Web of Science ®Google Scholar
• MatsuyamaTTanakaYKamimakiINagaoTTaokimitsuICatechin safely improved higher levels of fatness, blood pressure, and cholesterol in childrenObesity (Silver Spring)2008161338134818356827
   PubMed Web of Science ®Google Scholar
• FioriniRNDonovanJLRodwellDShort-term administration of (-)-epigallocatechin gallate reduces hepatic steatosis and protects against warm hepatic ischemia/reperfusion injury in steatotic miceLiver Transpl20051129830815719408
   PubMed Web of Science ®Google Scholar
• NishikawaTNakajimiTMoriguchiMA green tea polyphenol, epigalocatechin-3-gallate, induces apoptosis of human hepatocellular carcinoma, possibly through inhibition of Bcl-2 family proteinsJ Hepatol2006441074108216481065
   PubMed Web of Science ®Google Scholar
• BrunoRSDuganCESmythJADiNataleDAKooSIGreen tea extract protects leptin-deficient, spontaneously obese mice from hepatic steatosis and injuryJ Nutr200813832333118203899
   PubMed Web of Science ®Google Scholar
• PistersKMNewmanRAColdmanBShinDMKhuriFRHongWKPhase I trial of oral green tea extract in adult patients with solid tumorsJ Clin Oncol2001191830183811251015
   PubMed Web of Science ®Google Scholar
• EngmanMGranbergSWilliamsARMengCXLalitkumarPGGemzell-DanielssonKMifepristone for treatment of uterine leiomyoma. A prospective randomized placebo controlled trialHum Reprod2009241870187919389793
   PubMed Web of Science ®Google Scholar
• ChaoMTWadeCMSocioeconomic factors and women’s use of complementary and alternative medicine in four racial/ethnic groupsEthn Dis200818657118447102
   PubMed Web of Science ®Google Scholar